Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) recently reported its financial results for the fiscal year 2009, which included record sales of stevioside that reached $14.5 million for the full fiscal year of 2009, an increase of 12.4% over the $12.9 million recorded in fiscal 2008. Now the company, a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie stevia in China, has just issued additional news.

This morning, Sunwin International issued a press released announcing that it will present at the Rodman & Renshaw Annual Global Investment Conference taking place at the New York Palace Hotel September 9-11 as part of the Asia Track program on September 10th at 8:45 AM.

Sunwin's Chief Executive Officer, Dongdong Lin commented, "We are excited to be invited to the Rodman conference and look forward to presenting the exciting future of our company. Despite the global economic downturn, we have sustained our profitability and positioned the company for future growth. We intend to look to participate in additional conferences and meetings throughout the fall in order to increase the company's exposure to the investment community."

On July 30th, 2009, the company reported it's financial results for the fiscal year ended April 30, 2009. Sales of stevioside reached a record $14.5 million for the full fiscal year of 2009, an increase of 12.4% over the $12.9 million recorded in fiscal 2008. The global demand for stevioside continues to increase as regulatory authorities in the United States have approved the use of highly purified grades in the food and beverage industry. The strong performance in Sunwin's Stevioside Segment was more than offset by weakness in its Chinese and Veterinary Medicines Segment which was negatively impacted due to the global economic downturn, decreased breeding and farming production due to the swine flu pandemic and currency exchange rate fluctuations. As a result, for the full year of 2009 Sunwin International generated revenue of $22.21 million as compared to revenue of $22.93 million for the same period of 2008.

Cost of goods sold for the full fiscal year of 2009 increased slightly to $17.13 million, up approximately $280,000 as compared to fiscal 2008 resulting in gross margins decreasing to 23% as compared to 27% in fiscal 2008.